Dr Bishal Gyawali speaks to ecancer about the workshop at Choosing Wisely 2022 Mumbai, which focused on clinical trials.

His talk explored the control arm treatments in clinical trials for low-middle-income countries.

He concludes by stating that LMIC should be selective in spending resources only on those trials that are meaningful to their patients.